Product image of Mykofenolát Mofetil Sandoz (Mycophenolate Mofetil) supplied by GNH India

Mykofenolát Mofetil Sandoz

Active Ingredient:
Mycophenolate Mofetil
Origin:
EU

Mykofenolát Mofetil Sandoz (Mycophenolate Mofetil)

Mycophenolate Mofetil, the active ingredient in Mykofenolát Mofetil Sandoz, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to treat lupus nephritis by moderating the immune response in transplant recipients and patients with severe renal involvement of systemic lupus erythematosus.

GNH India supplies Mykofenolát Mofetil Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Manufacturer / TM Owner

Sandoz Pharmaceuticals D.D.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mykofenolát Mofetil Sandoz is an immunosuppressive antimetabolite used in conditions where immune modulation is required.

  • Organ transplant rejection: helps prevent graft loss by inhibiting lymphocyte proliferation.
  • Kidney transplant: maintains renal allograft function through sustained immune suppression.
  • Lupus nephritis: reduces renal inflammation and proteinuria in systemic lupus erythematosus.

How It Works

  • Mycophenolate Mofetil is converted intracellularly to mycophenolic acid, which selectively inhibits inosine monophosphate dehydrogenase. This blocks de novo guanosine nucleotide synthesis in activated T and B lymphocytes, limiting their proliferation and thereby dampening the adaptive immune response essential for graft rejection and autoimmune kidney injury.

Side Effects

Adverse reactions may range from mild to severe and should be monitored throughout therapy.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: frequent loose stools.
  • Headache: transient cranial discomfort.
  • Abdominal pain: cramping or discomfort.
  • Infections: increased susceptibility to bacterial and viral infections.

Serious or Rare Side Effects

  • Leukopenia: significant reduction in white blood cells.
  • Severe infections: opportunistic or life‑threatening infections.
  • Hepatotoxicity: elevated liver enzymes or liver injury.
  • Malignancy: increased risk of certain cancers with long‑term use.
  • Progressive multifocal leukoencephalopathy: rare demyelinating disease.

Precautions & Warnings

Careful monitoring and patient education are essential when using Mykofenolát Mofetil Sandoz.

  • Blood counts: monitor complete blood count regularly to detect leukopenia.
  • Renal function: assess serum creatinine and glomerular filtration rate.
  • Live vaccines: avoid administration while on therapy.
  • Pregnancy: contraindicated in pregnancy; use effective contraception.
  • Breastfeeding: not recommended due to drug excretion in milk.
  • Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mycophenolate Mofetil may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Azathioprine: additive bone‑marrow suppression.
  • Cyclosporine: increased risk of nephrotoxicity and infections.
  • Rifampin: reduces mycophenolate plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Antacids (aluminum or magnesium): may decrease absorption.
  • Warfarin: monitor INR for potential anticoagulant effect changes.
  • Live vaccines: heightened infection risk; consider timing.

Frequently Asked Questions

Mykofenolát Mofetil Sandoz contains mycophenolate mofetil, an immunosuppressant used to prevent organ transplant rejection and to treat lupus nephritis by reducing abnormal immune activity.

Mycophenolate mofetil is converted to mycophenolic acid, which blocks inosine monophosphate dehydrogenase, a key enzyme for guanosine synthesis in activated lymphocytes, thereby limiting T‑ and B‑cell proliferation.

The prescribed dose is individualized by the treating physician based on the specific indication, patient weight, renal function and concomitant therapies. Patients should follow the dosing instructions provided by their healthcare professional.

Mycophenolate mofetil is classified as Pregnancy Category D and is contraindicated in pregnancy due to teratogenic risk. It is also not recommended during breastfeeding because the drug can be excreted in breast milk.

Enquiries are submitted via the product page on gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with calcineurin inhibitors such as cyclosporine, mycophenolate mofetil offers a different mechanism—targeting nucleotide synthesis rather than calcineurin signaling—often resulting in a distinct side‑effect profile and may be used in combination for synergistic immunosuppression.

Store the product at temperatures below 25 °C, in the original container, protected from moisture and direct sunlight. Do not refrigerate or freeze unless specifically instructed by the manufacturer.

The medication is taken orally, usually with food or a glass of water, as directed by the prescribing clinician. Swallow tablets or capsules whole; do not crush or chew unless advised.

Serious risks include severe infections, leukopenia, liver toxicity, malignancies and rare neurological complications such as progressive multifocal leukoencephalopathy. Patients should be monitored regularly for these events.

Patients with known hypersensitivity to mycophenolate mofetil, active uncontrolled infections, severe renal impairment, or those who are pregnant or planning pregnancy should not use this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mycophenolate Mofetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT